89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 152 filers reported holding 89BIO INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930,214 | -87.6% | 60,247 | -84.8% | 0.28% | -87.9% |
| Q2 2023 | $7,513,618 | -22.7% | 396,497 | -37.9% | 2.32% | -42.1% |
| Q1 2023 | $9,720,014 | +571.3% | 638,215 | +155.3% | 4.01% | +718.8% |
| Q3 2022 | $1,448,000 | +176.3% | 250,000 | +791.8% | 0.49% | +109.4% |
| Q2 2021 | $524,000 | -55.7% | 28,032 | -43.9% | 0.23% | -63.8% |
| Q1 2021 | $1,184,000 | +10.4% | 50,007 | +13.6% | 0.65% | +3.7% |
| Q4 2020 | $1,072,000 | – | 44,007 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |